Last reviewed · How we verify
Magnesium Hydroaspartate — Competitive Intelligence Brief
unknown
magnesium aspartate
Gastroenterology
Live · refreshed every 30 min
Target snapshot
Magnesium Hydroaspartate (magnesium aspartate). Magnesium Hydroaspartate works by replenishing magnesium levels in the body, which helps to relax muscles and improve bowel function.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Magnesium Hydroaspartate TARGET | magnesium aspartate | unknown | magnesium aspartate |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (magnesium aspartate class)
- · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Magnesium Hydroaspartate CI watch — RSS
- Magnesium Hydroaspartate CI watch — Atom
- Magnesium Hydroaspartate CI watch — JSON
- Magnesium Hydroaspartate alone — RSS
- Whole magnesium aspartate class — RSS
Cite this brief
Drug Landscape (2026). Magnesium Hydroaspartate — Competitive Intelligence Brief. https://druglandscape.com/ci/magnesium-aspartate. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing